Patents by Inventor Keisuke Fukuchi
Keisuke Fukuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11870245Abstract: A surge suppression device includes a plurality of series circuits each of which is composed of a resistor and a capacitor, a case in which a plurality of the resistors and a plurality of the capacitors are placed, wherein respective ends of the plurality of series circuits on the capacitor side are electrically connected to each other via a connection electrode provided on the case. A motor wiring component includes a plurality of conductive wires connected to stator coils of the motor, wiring terminals that are provided at ends of the plurality of conductive wires on a side opposite to the side connected to the stator coils and are connected to electrodes of a terminal block, and the surge suppression device.Type: GrantFiled: February 22, 2022Date of Patent: January 9, 2024Assignee: PROTERIAL, LTD.Inventor: Keisuke Fukuchi
-
Publication number: 20230340118Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.Type: ApplicationFiled: May 10, 2023Publication date: October 26, 2023Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventors: Keisuke FUKUCHI, Kayoko NANAI, Masato AMANO, Kozo YONEDA, Yusuke TOTOKI, Shoji YAMAMOTO
-
Patent number: 11768114Abstract: A temperature sensor detects temperatures of at least two distribution lines and includes a temperature detection unit and a protection member that covers the temperature detection unit. The protection member is provided with a first abutting surface that has a concave shape corresponding to an outer shape of a first distribution line and is in contact with the first distribution line and a second abutting surface that has a concave shape corresponding to an outer shape of a second distribution line and is in contact with the second distribution line.Type: GrantFiled: October 22, 2020Date of Patent: September 26, 2023Assignees: Proterial, Ltd., Hitachi Astemo Electric Motor Systems, Ltd.Inventors: Keisuke Fukuchi, Masanori Sagawa, Masashi Yokoi
-
Publication number: 20230268104Abstract: A resistor includes a resistor main body, and a resin portion covering the resistor main body. The resin portion includes a radiation fin.Type: ApplicationFiled: February 22, 2023Publication date: August 24, 2023Applicant: Proterial, Ltd.Inventor: Keisuke FUKUCHI
-
Publication number: 20230178272Abstract: A resistor is composed of a resistor body part and a molded resin in which the resistor body part is embedded. The molded resin includes a base resin and a filler that is higher in thermal conductivity than the base resin.Type: ApplicationFiled: November 30, 2022Publication date: June 8, 2023Applicant: Hitachi Metals, Ltd.Inventor: Keisuke FUKUCHI
-
Patent number: 11661451Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.Type: GrantFiled: July 26, 2018Date of Patent: May 30, 2023Assignee: DAIICHI SANKYO COMPANY, LIMITEDInventors: Keisuke Fukuchi, Kayoko Nanai, Masato Amano, Kozo Yoneda, Yusuke Totoki, Shoji Yamamoto
-
Patent number: 11652382Abstract: A motor wiring member configured to supply three-phase alternating current to a motor includes conductive wires, each of which has a connecting portion being provided at one end and being configured to be connected to a coil end of a stator of the motor, a terminal being provided at an other end of each conductive wire and being configured to be connected to an electrode of a terminal block, and a surge suppression section being configured to suppress an overvoltage from being applied to the motor. The surge suppression section includes three series circuits, each of which includes a resistor and a capacitor. One ends of the three series circuits are electrically connected to the conductive wires of respective phases, and other ends of the three series circuits are electrically connected to each other. The surge suppression section is provided along with the conductor wires near the terminal and is located between the terminal and the connecting portion.Type: GrantFiled: August 4, 2021Date of Patent: May 16, 2023Assignee: PROTERIAL, LTD.Inventors: Masanori Sagawa, Yuta Sugiyama, Keisuke Fukuchi, Yukio Ikeda
-
Publication number: 20230009239Abstract: A wiring component with physical quantity sensor is provided with an electric wire, a physical quantity sensor to detect a physical quantity of the electric wire, a holding member that is composed of a molded body covering a portion in a longitudinal direction of the electric wire and has a holding hole to house the physical quantity sensor, and an attachment member attached to the holding member. The physical quantity sensor is prevented from coming out of the holding hole by the attachment member.Type: ApplicationFiled: July 1, 2022Publication date: January 12, 2023Inventor: Keisuke FUKUCHI
-
Publication number: 20220319738Abstract: A wiring component with physical quantity sensor is provided with a plurality of electric wires, a physical quantity sensor for detecting a physical quantity of the plurality of electric wires, an electric wire holding member including an intervening portion interposed between the plurality of electric wires, and a holder holding the physical quantity sensor. The electric wire holding member includes a protrusion protruding from the intervening portion in a direction perpendicular to an arrangement direction of the plurality of electric wires, and aligning the holder in longitudinal directions of the plurality of electric wires by the protrusion. The holder includes an electric wire engaging portion being engaged with at least one of the plurality of electric wires.Type: ApplicationFiled: March 28, 2022Publication date: October 6, 2022Inventor: Keisuke FUKUCHI
-
Patent number: 11459387Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.Type: GrantFiled: October 12, 2021Date of Patent: October 4, 2022Assignee: DAIICHI SANKYO COMPANY, LIMITEDInventors: Keisuke Fukuchi, Kayoko Nanai, Masato Amano, Kozo Yoneda, Yusuke Totoki, Shoji Yamamoto
-
Publication number: 20220294210Abstract: A surge suppression device includes a plurality of series circuits each of which is composed of a resistor and a capacitor, a case in which a plurality of the resistors and a plurality of the capacitors are placed, wherein respective ends of the plurality of series circuits on the capacitor side are electrically connected to each other via a connection electrode provided on the case. A motor wiring component includes a plurality of conductive wires connected to stator coils of the motor, wiring terminals that are provided at ends of the plurality of conductive wires on a side opposite to the side connected to the stator coils and are connected to electrodes of a terminal block, and the surge suppression device.Type: ApplicationFiled: February 22, 2022Publication date: September 15, 2022Inventor: Keisuke FUKUCHI
-
Publication number: 20220278592Abstract: A physical quantity detection device is provided with first and second retainers arranged to sandwich a wire, and a physical quantity sensor fixed to the wire by the first and second retainers. The physical quantity of the wire is detected by the physical quantity sensor, and the first and second retainers are fixed to the wire by being locked with each other.Type: ApplicationFiled: February 22, 2022Publication date: September 1, 2022Inventor: Keisuke FUKUCHI
-
Publication number: 20220231467Abstract: A wiring component with temperature sensor includes an electric wire, a temperature sensor including a detection unit configured to detect temperature of the electric wire and a plurality of lead wires, and a plurality of connector pins respectively connected to the plurality of lead wires. The electric wire, the temperature sensor and the plurality of connector pins are collectively held by a holder made of a resin. The holder includes a connector housing member configured to hold the plurality of connector pins and a molded resin member covering a portion of the connector housing member.Type: ApplicationFiled: December 16, 2021Publication date: July 21, 2022Inventors: Keisuke FUKUCHI, Junjie SHEN
-
Publication number: 20220221361Abstract: A physical quantity sensor-fixing structure includes a holder holding a physical quantity sensor including a detection unit to detect a physical quantity and a plurality of lead wires connected to the detection unit. The holder fixes the physical quantity sensor to a plurality of conductive support members to be respectively connected to the plurality of lead wires. The holder includes a main body member including a housing portion to house at least a portion of the physical quantity sensor, and a lid member covering at least a portion of the housing portion.Type: ApplicationFiled: December 22, 2021Publication date: July 14, 2022Inventor: Keisuke FUKUCHI
-
Publication number: 20220106393Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.Type: ApplicationFiled: October 12, 2021Publication date: April 7, 2022Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventors: Keisuke FUKUCHI, Kayoko NANAI, Masato AMANO, Kozo YONEDA, Yusuke TOTOKI, Shoji YAMAMOTO
-
Publication number: 20220045570Abstract: A motor wiring member configured to supply three-phase alternating current to a motor includes conductive wires, each of which has a connecting portion being provided at one end and being configured to be connected to a coil end of a stator of the motor, a terminal being provided at an other end of each conductive wire and being configured to be connected to an electrode of a terminal block, and a surge suppression section being configured to suppress an overvoltage from being applied to the motor. The surge suppression section includes three series circuits, each of which includes a resistor and a capacitor. One ends of the three series circuits are electrically connected to the conductive wires of respective phases, and other ends of the three series circuits are electrically connected to each other. The surge suppression section is provided along with the conductor wires near the terminal and is located between the terminal and the connecting portion.Type: ApplicationFiled: August 4, 2021Publication date: February 10, 2022Inventors: Masanori SAGAWA, Yuta SUGIYAMA, Keisuke FUKUCHI, Yukio IKEDA
-
Patent number: 10995143Abstract: The present invention relates to the medical use of antibodies against the FGF receptor 4 (FGFR4) combined with Sorafenib, in particular for the prevention or treatment of hyperproliferative diseases associated with FGFR expression, overexpression or hyperactivity.Type: GrantFiled: February 9, 2017Date of Patent: May 4, 2021Assignees: Daiichi Sankyo Europe GmbH, Daiichi Sankyo Company LimitedInventors: Reimar Abraham, Keisuke Fukuchi
-
Publication number: 20210123811Abstract: A temperature sensor detects temperatures of at least two distribution lines and includes a temperature detection unit and a protection member that covers the temperature detection unit. The protection member is provided with a first abutting surface that has a concave shape corresponding to an outer shape of a first distribution line and is in contact with the first distribution line and a second abutting surface that has a concave shape corresponding to an outer shape of a second distribution line and is in contact with the second distribution line.Type: ApplicationFiled: October 22, 2020Publication date: April 29, 2021Inventors: Keisuke Fukuchi, Masanori Sagawa, Masashi Yokoi
-
Publication number: 20200362033Abstract: An object of the present invention is to provide a novel anti-CD147 antibody exhibiting potent antitumor efficacy and having excellent safety. Another object of the present invention is to provide a pharmaceutical product comprising such an antibody. Another object of the present invention is to provide a method for treating tumors using the antibody or the pharmaceutical product, for example. The present invention provides a CD147-specific antibody that activates CD147 and exhibits high antitumor efficacy. The present invention provides the anti-CD147 antibody that exhibits high antitumor efficacy independent of effector functions. The present invention provides a pharmaceutical composition comprising such an anti-CD147 antibody. The present invention provides a method for treating tumors using such an anti-CD147 antibody and/or pharmaceutical composition.Type: ApplicationFiled: July 26, 2018Publication date: November 19, 2020Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventors: Keisuke FUKUCHI, Kayoko NANAI, Masato AMANO, Kozo YONEDA, Yusuke TOTOKI, Shoji YAMAMOTO
-
Patent number: 10358498Abstract: The present invention relates to novel antibodies against the FGF receptor 4 (FGFR4) and to the medical use thereof, in particular for the diagnosis prevention or treatment of diseases associated with FGFR expression, over expression or hyperactivity.Type: GrantFiled: August 11, 2015Date of Patent: July 23, 2019Assignees: Daiichi Sankyo Europe GmbH, Daiichi Sankyo Company, LimitedInventors: Reimar Abraham, Keisuke Fukuchi, Tanja Lange, Johannes Bange, Ichiro Watanabe, Shinko Hayashi, Toshiaki Ohtsuka